How much is Diagonal Therapeutics worth in 2026?

Diagonal Therapeutics has a current valuation of N/A based on their Early Stage VC (Series B) round and secondary market data.

How much funding has Diagonal Therapeutics raised?

Diagonal Therapeutics has raised N/A in total funding across 2 funding rounds.

Diagonal Therapeutics

Drug Discovery

Diagonal Therapeutics valuation and funding history | Last updated: January 8, 2026 | 2 funding rounds

Current Valuation

N/A

As of January 8, 2026

Total Funding Raised

N/A

Across 2 rounds

Last Round

Early Stage VC (Series B)

$125.0M

Last Funding

Jan 2026

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
January 8, 2026	Early Stage VC (Series B)	$125.0M	N/A	-
April 3, 2024	Early Stage VC (Series A)	$128.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Diagonal Therapeutics is currently valued at N/A as of January 8, 2026.

Track Diagonal Therapeutics Valuation Updates

Get notified when Diagonal Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Diagonal Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Diagonal Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Diagonal Therapeutics Worth in 2026?

Diagonal Therapeutics is a leading private company in the Drug Discovery sector. Track Diagonal Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Diagonal Therapeutics Valuation is Determined

Private company valuations like Diagonal Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.